Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha Fauser

Showing results (191-200 of 237) with videos related to

Pageof 24
Sort By:
Ophthalmology|July 31, 2012
Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degenerationDzenita Smailhodzic, Philipp S Muether, John Chen, et al.
The British Journal of Ophthalmology|November 2, 2017
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT studyChristoph Paul, Christine Heun, Hans-Helge Müller, et al.
Ophthalmology|June 9, 2022
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical TrialFriederike Schaub, Petra Schiller, Robert Hoerster, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYHelena M A Feenstra, Roselie M H Diederen, Martine J C M Lamme, et al.
Ophthalmology|May 20, 2018
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE TrialElon H C van Dijk, Sascha Fauser, Myrte B Breukink, et al.
Ophthalmology|March 27, 2019
ReplyElon H C van Dijk, Sascha Fauser, Myrte B Breukink, et al.
Ophthalmology|November 25, 2018
ReplyElon H C van Dijk, Sascha Fauser, Myrte B Breukink, et al.
Retina (Philadelphia, Pa.)|January 5, 2024
LASER FLARE PHOTOMETRY IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT: An Evaluation of 2,487 CasesCaroline Gietzelt, Robert Hoerster, Petra Schiller, et al.
Ophthalmology|November 30, 2020
Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK ConsortiumJohanna M Colijn, Magda Meester-Smoor, Timo Verzijden, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 17, 2020
[Correction: Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections]Michael Janusz Koss, Matthias Bolz, Albert J Augustin, et al.
Pageof 24

Showing results (191-200 of 237) with videos related to

Sort By:
Pageof 24
Ophthalmology|July 31, 2012
Cumulative effect of risk alleles in CFH, ARMS2, and VEGFA on the response to ranibizumab treatment in age-related macular degenerationDzenita Smailhodzic, Philipp S Muether, John Chen, et al.
The British Journal of Ophthalmology|November 2, 2017
Calculating the individual probability of successful ocriplasmin treatment in eyes with VMT syndrome: a multivariable prediction model from the EXPORT studyChristoph Paul, Christine Heun, Hans-Helge Müller, et al.
Ophthalmology|June 9, 2022
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical TrialFriederike Schaub, Petra Schiller, Robert Hoerster, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHYHelena M A Feenstra, Roselie M H Diederen, Martine J C M Lamme, et al.
Ophthalmology|May 20, 2018
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE TrialElon H C van Dijk, Sascha Fauser, Myrte B Breukink, et al.
Ophthalmology|March 27, 2019
ReplyElon H C van Dijk, Sascha Fauser, Myrte B Breukink, et al.
Ophthalmology|November 25, 2018
ReplyElon H C van Dijk, Sascha Fauser, Myrte B Breukink, et al.
Retina (Philadelphia, Pa.)|January 5, 2024
LASER FLARE PHOTOMETRY IN PRIMARY RHEGMATOGENOUS RETINAL DETACHMENT: An Evaluation of 2,487 CasesCaroline Gietzelt, Robert Hoerster, Petra Schiller, et al.
Ophthalmology|November 30, 2020
Genetic Risk, Lifestyle, and Age-Related Macular Degeneration in Europe: The EYE-RISK ConsortiumJohanna M Colijn, Magda Meester-Smoor, Timo Verzijden, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 17, 2020
[Correction: Safety, Efficacy and Protective Aspects of an Add-on Paracentesis during Intravitreal Injections]Michael Janusz Koss, Matthias Bolz, Albert J Augustin, et al.
Pageof 24